PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID)
Vol. 1 No. 3 (2022): JULY

SELF-ATTITUDE TOWARDS SKIN HEALTH IN ADOLESCENTS

Irmazida, Nela Hilmiana (Unknown)
Apriliana, Eka Rida (Unknown)
Al Zuhrah, Nurul Faridah (Unknown)
Febriarta, Ajie (Unknown)
Wahyuni, Putri (Unknown)
Quraini, Annisa (Unknown)
Yulanda, Prasetyani Fitri (Unknown)
Setiyowati, Eppy (Unknown)



Article Info

Publish Date
23 Feb 2023

Abstract

Teenagers frequently underestimate and disregard personal hygiene, which has a negative impact on health. The aim of this study was to analyze self-attitude towards skin health in adolescents. This study employs descriptive analytic techniques. The sample was selected by simple random sampling technique, namely probability sampling with the Spearman test statistic. A sample of 36 teenage respondents in the Mulyorejo Baru area, Surabaya City. The results showed that 0 respondents (0%) had good self-esteem with good skin health, 1 respondent (2.8%) had good self-esteem with good skin health, had a good attitude towards health bad skin as much as 0 respondents (0%). Then, for students with adequate self-esteem and good skin health, there were as many as 23 respondents (63,9%), adequate self-esteem with moderate skin health, as many as 6 respondents (16,7%), and adequate self-esteem with bad skin health, there were as many as 0 respondents (0%). From the research that has been done, it can be concluded that the self-esteem of adolescents in the Mulyorejo Baru area, Surabaya City and skin health does not have a significant relationship based on the Spearman test p: 0,294.

Copyrights © 2022






Journal Info

Abbrev

COMORBID

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology Neuroscience Nursing

Description

About the Journal PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID) is an international, modern, general medical publication that publishes research on all aspects of medicine, from fundamental research to significant clinical trials and cost-effectiveness analyses. We ...